Nov 30, 2023 Biden Administration Promotes Domestic Pharmaceutical Production to Reduce Drug Shortages By Chad Landmon I'm not saying that anyone from the Biden administration was reading my blog post last week on drug shortages, and maybe it's just a...
Nov 29, 2023 Motorola v. Hytera: Seventh Circuit Set to Hear Arguments on the Extraterritorial Reach of DTSA By Matt Murphy Nicholas Duffee On December 5, the Seventh Circuit in Motorola Solutions, Inc. v. Hytera Communications Corp. will hear high-stakes arguments concerning...
Nov 27, 2023 The Federal Circuit Spins a Yarn By Ted Mathias Matt Murphy The Federal Circuit's decision on claim construction, Barrday, Inc. v. Lincoln Fabrics, Inc., 2023-1903, 2023 WL 7871688 (Fed. Cir. Nov....
Nov 27, 2023 Are Drugmakers Gaming the Patent System? By Chad Landmon We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price...
Nov 21, 2023 Empowering Career Development at CYOC By Axinn Events Axinn is a proud supporter of this year's Charting Your Own Course (CYOC) Career Development Conference, hosted by Stakeholders. For...
Nov 21, 2023 Thankful for Pharmaceuticals . . . Especially When There are Shortages By Chad Landmon When our children were young, we started a tradition at Thanksgiving of going around the table and having each of us (around 20 with...
Nov 20, 2023 Trade Secrets, ET, and the ITC By Matt Murphy Brian Johnson The U.S. International Trade Commission (ITC) has broad power to issue exclusion orders blocking the importation of goods determined to...
Nov 20, 2023 The Sewage of Expert Report Deadlines By Ted Mathias Expert report deadlines are a feature of every patent case's scheduling order, but they nevertheless are the constant source of disputes....
Nov 17, 2023 Advanced EU Competition Law Brussels By Axinn Events Join Axinn partners Tiffany Rider, Jimmy Attridge, and Nick Gaglio in Brussels from November 20-22 at CompLaw's Advanced EU Competition...
Nov 16, 2023 Cooperation or Collusion? FTC Defends Interagency Contacts By Lisl Dunlop Does interaction between the Federal Trade Commission and other antitrust enforcers around the world benefit merging parties, or does it...
Nov 16, 2023 The Sneaky-Powerful Defense That Came Up Short - This Time By Ted Mathias A great thing about patent litigation is the vast array of legal doctrines, arguments, and defenses that can come up in any given case....
Nov 16, 2023 DOJ Provides More Specific Guidance About Criminal Enforcement of Section 2 By Jimmy Attridge Since the Antitrust Division's March 2022 announcement that it would once again consider and bring criminal charges for violations of...
Nov 15, 2023 Soccer Antitrust Case Looking Like a Vehicle for Supreme Court to Prune Section 1 Antitrust Cases By Mike Keeley The U.S. Supreme Court is signaling its interest in a cert petition by U.S. Soccer by asking the DOJ to weigh in on whether to take up...
Nov 15, 2023 Ending Where It Began?: DOJ No-Poach Prosecutions Take Another Hit By Dan Oakes The Department of Justice’s years-long campaign to criminally prosecute no-poach agreements may be taking a hiatus. On November 13, 2023,...
Nov 15, 2023 Has Chevron Deference Increased Polarization? By Chad Landmon I think that we can all agree that political polarization is incredibly high right now. But is Chevron deference partly to blame?...
Nov 13, 2023 No Voluntary Delistings or Disputes in FDA's Orange Book Update By Chad Landmon Matt Murphy Ross Blau FTC recently placed improper Orange Book patent listings squarely in its crosshairs. In its September 2023 policy statement, FTC...